Description

Description

Jardy-Met XR 5/1000mg is a once-daily, extended-release combination tablet designed to make dual-action diabetes treatment more convenient, packaged 14 tablets to a pack. It is built with an extended-release Metformin core, which releases the medicine gradually over several hours, wrapped in an outer layer containing Empagliflozin that is absorbed more quickly. Empagliflozin works as an SGLT2 inhibitor, encouraging the kidneys to remove surplus glucose through urine, while the extended-release Metformin steadily reduces the liver’s glucose output and improves the body’s sensitivity to its own insulin throughout the day. This XR design allows patients to move from twice-daily immediate-release dosing to a simpler once-daily tablet, while aiming to maintain smoother blood sugar control and generally milder digestive side effects.

Ingredients

Each Jardy-Met XR 5/1000mg tablet contains:

• Empagliflozin – 5 mg (immediate-release outer layer)
• Metformin Hydrochloride – 1000 mg (extended-release core)

The tablet also includes standard inactive excipients that form the extended-release matrix and outer film coating, which control the gradual release of Metformin and support easy swallowing, without contributing any therapeutic effect themselves.

Dosage Form

Jardy-Met XR 5/1000mg is manufactured as an extended-release, film-coated oral tablet, supplied 14 tablets per pack, intended for once-daily oral use.

Uses

Jardy-Met XR 5/1000mg is generally prescribed to:

• Improve blood glucose control in adults with type 2 diabetes mellitus who are not adequately managed on Metformin or Empagliflozin alone
• Allow patients already stabilized on immediate-release Empagliflozin and Metformin to transition to a simpler once-daily extended-release regimen
• Support long-term glycemic management, including potential cardiovascular and kidney-related benefits, when combined with a suitable diet and consistent physical activity

It is not intended for people with type 1 diabetes or for the management of diabetic ketoacidosis.

How to Use

The following points are general guidance only — always follow the specific instructions given by your prescribing doctor:

• Take the tablet once daily, generally with the evening meal, as directed by your doctor.
• Swallow the tablet whole with a glass of water; because it is extended-release, it must never be crushed, split, or chewed, as doing so can release the full dose too quickly.
• It is normal to occasionally notice the tablet shell in the stool, since the outer matrix that controls the slow release is not fully absorbed; this does not mean the medicine wasn’t effective.
• Maintain a consistent daily timing to help support steady blood sugar management.
• Keep up with recommended blood tests, including kidney function monitoring, since ongoing use depends on adequate kidney health.

Side Effects

Side effects can vary between individuals, but commonly reported ones with this combination include:

• Nausea, diarrhea, or general stomach discomfort, typically milder and less frequent than with immediate-release metformin, especially once the body adjusts
• Reduced appetite or a metallic taste in the mouth
• Increased urinary frequency
• Mild dehydration or increased thirst
• Urinary tract or genital yeast infections

Less commonly, more serious concerns can occur, including lactic acidosis, a rare but serious risk associated with metformin that is more likely in people with reduced kidney or liver function, signs of dehydration with low blood pressure, or symptoms suggesting diabetic ketoacidosis such as persistent nausea, vomiting, or abdominal pain even when blood sugar readings appear normal. Any of these symptoms call for urgent medical attention. This overview is not exhaustive, so any unusual or persistent symptom should be discussed with a doctor or pharmacist.

Pregnancy & Breastfeeding

Jardy-Met XR is generally not recommended during pregnancy, since the Empagliflozin component may affect fetal kidney development, particularly in later stages of pregnancy, and diabetes management in pregnant women is typically handled through alternative approved treatments under specialist care. It is also generally not advised during breastfeeding. Women who are pregnant, planning to become pregnant, or currently breastfeeding should speak with their doctor before starting or continuing this medication.

Storage Instructions

• Store Jardy-Met XR tablets at room temperature, ideally below 25°C, away from direct sunlight, heat, and excess humidity.
• Keep tablets in their original blister packaging until they are needed.
• Store out of reach of children.
• Do not use tablets past their printed expiry date, and dispose of unused medicine responsibly rather than through household waste.

FAQS

What does “XR” mean, and how is it different from regular Jardy-Met?
XR stands for extended-release, meaning the Metformin portion is released gradually over time, allowing once-daily dosing instead of the twice-daily schedule usually needed for standard Jardy-Met tablets.

Why can’t I crush or split this tablet?
Doing so would break the extended-release mechanism, causing the full metformin dose to be released at once rather than gradually, which can increase the risk of side effects.

Is it normal to see something resembling the tablet in my stool?
Yes, the outer shell that controls the slow release of medicine is not fully broken down and may appear intact in the stool; this does not mean the dose was not absorbed.

Does the extended-release form cause fewer digestive side effects?
Many patients find the gradual release gentler on the stomach compared with immediate-release metformin, though some digestive symptoms can still occur, especially early in treatment.

Can I switch from twice-daily Jardy-Met to once-daily Jardy-Met XR on my own?
No, any switch between formulations should be guided by your doctor, who will ensure the total daily dose and timing are appropriate for your treatment plan.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.